2C-G-N
Width225px
Routes of administrationOral[1]
ClassPsychoactive drug; Stimulant; Antidepressant
Atc prefixNone
Duration of action20–30 hours[1]
Cas number207740-21-4
Pubchem21796713
Chemspiderid10546842
UniiO5LSQ8027D
Chembl332505
Synonyms2C-G-NPH; 2C-NPH; 1,4-Dimethoxynaphthyl-2-ethylamine
Iupac name2-(1,4-dimethoxynaphthalen-2-yl)ethanamine
C14
H17
N1
O2
SmilesCOC1=CC(=C(C2=CC=CC=C21)OC)CCN
Stdinchi1S/C14H17NO2/c1-16-13-9-10(7-8-15)14(17-2)12-6-4-3-5-11(12)13/h3-6,9H,7-8,15H2,1-2H3
StdinchikeyVKWQEEWEGKDTDE-UHFFFAOYSA-N

2C-G-N, or 2C-G-NPH, also known as 1,4-dimethoxynaphthyl-2-ethylamine, is a psychoactive drug of the phenethylamine, 2C, and naphthylethylamine families.[1] It is the derivative of 2C-G in which the 3,4-dimethyl groups have been extended and connected to form a second benzene ring and hence has a 2-naphthalene ring system.[1]

In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists 2C-G-N's dose as 20 to 40 mg orally and its duration as 20 to 30 hours.[1][2][3] The effects of the drug were reported to include some amphetamine-like stimulation, some possible antidepressant-like effects, "not much psychedelic" but "something really going on anyway", faint uneasiness, and "not as friendly" of effects as other 2C-G compounds.[1] Its activity was described as "on the wane" compared to other 2C-G drugs and as lasting "too long".[1]

The chemical synthesis of 2C-G-N has been described.[1]

The drug was first described in the literature by Shulgin in PiHKAL in 1991.[1] It is a controlled substance in Canada under phenethylamine blanket-ban language.[4]

See also

References

  1. ^ https://www.erowid.org/library/books_online/pihkal/pihkal031.shtml
  2. ^ Jacob P, Shulgin AT (1994). "Structure-Activity Relationships of the Classic Hallucinogens and Their Analogs". Hallucinogens: An Update. Vol. 146. National Institute on Drug Abuse Research Monograph Series. National Institute on Drug Abuse. pp. 74–91. PMID 8742795. Archived 13 July 2025 at the Wayback Machine.
  3. ^ Shulgin AT (2003). "Basic Pharmacology and Effects". Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN 978-0-12-433951-4. Archived 13 July 2025 at the Wayback Machine.
  4. ^ "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.